Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

WGS vs BLLN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BLLN Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

BLLN Overall Winner 6-Pillar Tally: WGS 2 – 4 BLLN Matrix Metrics: WGS 3 – 7 BLLN

As of Nov 16, 2026, BillionToOne, Inc. (BLLN) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas BLLN carries 45.8/100 (HOLD) at $96.31 (61.3x Forward P/E, 10.2% operating margin).

  • Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. BLLN 45.8/100 HOLD), BLLN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (10.2% vs. -13.7% operating margin) and revenue trajectory (+47.2% vs. +5.4% YoY).
  • Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile BLLN is in a Breakdown options structure phase (RSI 34.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WGS vs BLLN
WGS NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap $1.6B
TTM Revenue $461M
Forward P/E 40.6x
Beta / 30D Vol 1.74β · 111% Vol
Unified Composite Score
49.5 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 35
RSI-14: 34.8 · SMA20: $62.47 · SMA50: $73.13
BLLN US Equity Head-to-Head Winner
BillionToOne, Inc.
Services-Medical Laboratories
$96.31
-8.41% 1D
Market Cap $5.0B
TTM Revenue $437M
Forward P/E 61.3x
Beta / 30D Vol 1.44β · 42% Vol
Unified Composite Score
45.8 / 100 HOLD
Tech 27.0 Fund 53.0 Flow 71.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 34
RSI-14: 34.4 · SMA20: $109.99 · SMA50: $106.93

6-Pillar Scorecard Institutional Category Breakdown (WGS 2 – 4 BLLN)

Columns: Metric · WGS · BLLN
1. Valuation Multiples WGS
Forward P/E 40.6x 61.3x
Trailing P/E 38.8x 114.3x
PEG Ratio N/M N/M
EV / Revenue 3.7x 10.5x
2. Growth & Scale BLLN
Revenue Growth (YoY) +5.4% +47.2%
Earnings Growth (YoY) +0.0% +220.0%
TTM Revenue (USD) $461M $437M
Market Cap $1.6B $5.0B
3. Profitability & Quality BLLN
Gross Margin 68.8% 71.4%
Operating Margin -13.7% 10.2%
Net Profit Margin -24.1% 10.5%
Return on Equity (ROE) -41.4% 13.2%
4. Balance Sheet & Cash Flow BLLN
Cash Generation (TTM) -$101M $34M
Cash Flow Margin -22.0% 7.8%
Net Cash / Leverage $119M Net Debt (0.88x D/E) $421M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BLLN
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 102.3% (21st %ile) 113.8% (26th %ile)
Put/Call OI Skew 7.82x (Put-Skewed) 1.21x (Put-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat WGS
OpEx & R&D Intensity 82.5% of Rev ($380M) 61.2% of Rev ($267M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Diagnostics & Research Operator Diagnostics & Research Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WGS (3) vs BLLN (7)
Institutional Metric WGS BLLN Criterion Row Edge
Market Capitalization
Scale
$1.6B $5.0B Larger Scale BLLN
Trailing P/E Ratio
Valuation
38.8x 114.3x Lower Multiple WGS
Forward P/E Ratio
Valuation
40.6x 61.3x Lower Multiple WGS
Revenue Growth (YoY)
Growth
+5.4% +47.2% Higher Growth BLLN
Operating Margin (TTM)
Profitability
-13.7% 10.2% Higher Margin BLLN
Net Profit Margin
Profitability
-24.1% 10.5% Higher Margin BLLN
Return on Equity (ROE)
Capital Efficiency
-41.4% 13.2% Higher ROE BLLN
52-Week Range Position
Momentum
14% ($32–$171) 39% ($62–$150) Stronger Trend BLLN
Beta / 30D Volatility
Risk Regime
1.74β · 111% Vol 1.44β · 42% Vol Lower Realized Risk BLLN
Unified Institutional Score
Composite Signal
49.5 / 100 (HOLD) 45.8 / 100 (HOLD) Higher Composite WGS
Trailing 12M Revenue (USD)
Operating Scale
$461M $437M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
68.8% 71.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.7x EV/Rev N/M PEG · 10.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$101M ($119M Net Debt (0.88x D/E)) $34M ($421M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BLLN +17.95 pp
WGS: -19.79% · BLLN: -1.84%
3M Horizon BLLN +42.63 pp
WGS: -33.17% · BLLN: +9.46%
6M Horizon WGS +7.68 pp
WGS: +19.51% · BLLN: +11.83%
1Y Horizon BLLN +68.41 pp
WGS: -60.86% · BLLN: +7.55%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period WGS Revenue BLLN Revenue WGS Op. Margin BLLN Op. Margin Margin Leader
FY2019 $200M N/A -15.5% N/A WGS
FY2020 $180M N/A -134.9% N/A WGS
FY2021 $210M N/A -210.3% N/A WGS
FY2022 $230M N/A -284.5% N/A WGS
FY2023 $200M $70M -89.2% -96.9% WGS
FY2024 $310M $150M -7.6% -30.9% WGS
FY2025 $430M $310M -3.1% 5.3% BLLN

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WGS BREAKDOWN
96d in phase · OBV DISTRIBUTION
Current IV 102.3%
IV Percentile 21st %ile
Put/Call OI Skew 7.82x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact WGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BLLN BREAKDOWN
78d in phase · OBV DISTRIBUTION
Current IV 113.8%
IV Percentile 26th %ile
Put/Call OI Skew 1.21x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact BLLN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WGS Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $1.6B market capitalization and -13.7% operating margin.
OpEx & R&D Reinvestment 82.5% of Rev ($380M)
90D Engineering Disclosures 0 Published
BLLN Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $5.0B market capitalization and 10.2% operating margin.
OpEx & R&D Reinvestment 61.2% of Rev ($267M)
90D Engineering Disclosures 0 Published

Investor FAQ WGS vs BLLN Key Questions & Quantitative Answers

As of Nov 16, 2026, BillionToOne, Inc. (BLLN) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas BLLN carries 45.8/100 (HOLD) at $96.31 (61.3x Forward P/E, 10.2% operating margin). Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. BLLN 45.8/100 HOLD), BLLN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (10.2% vs. -13.7% operating margin) and revenue trajectory (+47.2% vs. +5.4% YoY). Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile BLLN is in a Breakdown options structure phase (RSI 34.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BLLN leads the Growth & Scale pillar: WGS posts +5.4% YoY revenue growth and +0.0% YoY earnings growth on $461M TTM revenue (68.8% gross margin, -13.7% operating margin), compared with BLLN at +47.2% YoY revenue growth and +220.0% YoY earnings growth on $437M TTM revenue (71.4% gross margin, 10.2% operating margin). Across the 7-period historical trajectory (FY2019 to FY2025), WGS cumulative revenue shifted +115.0% while BLLN shifted +342.9%. In operating R&D and SG&A reinvestment, WGS deploys 82.5% of Rev ($380M) (0 90-day corporate R&D disclosures) versus 61.2% of Rev ($267M) (0 disclosures) for BLLN.

WGS screens cheaper on headline valuation multiples. WGS trades at 40.6x Forward P/E, 38.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (-22.0% FCF margin), whereas BLLN trades at 61.3x Forward P/E, 114.3x Trailing P/E, N/M PEG, and 10.5x EV/Revenue (7.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WGS (-41.4% ROE) versus BLLN (13.2% ROE) capital efficiency.

In options market volatility and institutional positioning, WGS carries 102.3% implied volatility (21st %ile, Compressed (<25th %ile)), a 7.82x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.74β · 111% Vol realized risk). By comparison, BLLN carries 113.8% implied volatility (26th %ile, Balanced (25th–60th %ile)), a 1.21x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.44β · 42% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.